Search results for "U.S. Phase 3 clinical trial"

Complete Remission in Metastatic Pancreatic Cancer: Nesuparib Shows Early Clinical Promise

Complete Remission in Metastatic Pancreatic Cancer: Nesuparib Shows Early Clinical Promise

Early clinical data point to extended survival and the rare possibility of complete remission in metastatic pancreatic cancer, a malignancy...
Ebola spreads rapidly in DRC—how far have new vaccines and treatments come?

Ebola spreads rapidly in DRC—how far have new vaccines and treatments come?

A Reuters report said the U.K. media outlet The Guardian reported on the 19th (20th in Korea time) that the World Health Organization is considering...
ABL Bio to Present Two Bispecific Antibody ADC Posters at AACR

ABL Bio to Present Two Bispecific Antibody ADC Posters at AACR

ABL Bio announced on the 19th that it will participate in this year’s American Association for Cancer Research Annual...
Idience Targeted Cancer Drug Candidate ‘Venadaparib’ Granted FDA Fast Track Designation

Idience Targeted Cancer Drug Candidate ‘Venadaparib’ Granted FDA Fast Track Designation

Idience, a novel anticancer drug developer under the Ildong Pharmaceutical Group, announced on the 18th that its...
Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR

Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR

Rznomics, a biotechnology company specializing in RNA-based gene therapies, announced on March 5 that it has been...
K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval

K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval

South Korean pharmaceutical and biotech companies are aggressively pursuing product approvals and clinical trials with...
High Efficacy and Increased Convenience: The Three Obesity Drugs Awaiting FDA Approval

High Efficacy and Increased Convenience: The Three Obesity Drugs Awaiting FDA Approval

Since the World Health Organization recommended the use of obesity medications for adults last December, the market is...
Dementia Injection Drug ‘Lecanemab’ Formulation and Dosage Diversification... Will It Compete with Oral Medications?

Dementia Injection Drug ‘Lecanemab’ Formulation and Dosage Diversification... Will It Compete with Oral Medications?

American Biogen and Japanese Eisai are moving quickly to change the formulation and dosage of the dementia treatment...
HK Innoen's 'K-Cab' Applies for New Drug Approval from the U.S. FDA

HK Innoen's 'K-Cab' Applies for New Drug Approval from the U.S. FDA

HK Innoen announced on the 13th that its U.S. partner, Sevela Pharmaceuticals, a subsidiary and specialist in...
SK Biopharm Receives FDA Approval for Clinical Trial Plan of Alpha-emitting Radiopharmaceuticals

SK Biopharm Receives FDA Approval for Clinical Trial Plan of Alpha-emitting Radiopharmaceuticals

SK Biopharm announced on the 12th that it has received approval from the U.S. Food and Drug Administration for the...